Leveraging 505(b)(2): Real-World Evidence Rescues Program
Source: Premier Consulting
A biotech company could not afford the time and expense of conducting studies recommended by another of its consultants and agreed to by the FDA. Through analysis of the product’s scientific and medical viability, we identified a possible alternative solution. Using our proprietary search methods, our researchers identified key publications to support the 505(b)(2) development plan.
Discover our process in assisting this sponsor in meeting its desired development cost and timeline goals.
VIEW THE ARTICLE! Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader X
Subscribe to Clinical Leader